Probiotic shows promise in MS immune control trial
NCT ID NCT07168772
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study tests whether taking a probiotic twice a day for six months can help people with relapsing-remitting multiple sclerosis (MS). The goal is to see if the probiotic increases certain immune cells (Treg cells) that may help control the disease. 80 adults with MS will be randomly assigned to receive either the probiotic or a placebo. This is an early-stage trial focused on immune system changes, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre d'Esclerosi Mútiple de Catalunya (Cemcat)
RECRUITINGBarcelona, Barcelona, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.